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Renal metabolism of drugs and their effects on
tubular function depend on the entry of the drug in-
to specific renal cells. In turn, this depends on dif-
ferential regional blood flow and the relative rates of
delivery of the drug to luminal and contraluminal
surfaces of the cell following filtration at the glomer-
ulus. In studies of renal pharmacology, it is desir-
able to have an intact kidney with a clearly defined
experimental system. Such conditions are provided
in part by the isolated perfused rat kidney, in which
a buffered, oxygenated medium containing only bo-
vine serum albumin in Krebs-Henseleit saline is
perfused into the renal artery. Glomerular filtration,
fractional sodium reabsorption, and the composi-
tion of the recirculated perfusate, as well as the
urine and the kidney itself, can all be analyzed.
Bowman [1] has recently outlined the perfusion
methods relevant to pharmacology. This paper
briefly reviews the approaches to renal drug han-
dling and drug effects using the isolated perfused
kidney. Its main purpose is to report detailed stud-
ies with tritiated paracetamol demonstrating direct
renal involvement in metabolism of this drug and to
offer possible mechanisms for the development of
analgesic nephropathy and nephrotoxicity of other
drugs.
Advantages of an isolated perfused kidney
in drug metabolism
The perfused rat kidney preparation permits mea-
surement of virtually any renal physiologic function
that can be measured in vivo [2]. In vivo, any physi-
ologic measurement may be used as a "test of func-
tion" in expressing the effects of a drug. In addi-
tion, biochemical properties, rates of intermediary
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metabolism, metabolite patterns of the kidney, total
oxygen consumption, and the effects of adding
single metabolic substrates on any of these process-
es can also be used as tests of function. By the
simple device of recirculation of perfusion medium,
metabolic rates in the isolated kidney can be magni-
fied and measured. The effects of a drug on any of
these functions can be determined by adding the
drug to the perfusion medium. An in vitro model, by
avoiding effects of the drug on other organs, in the
whole animal, means that virtually any water-sol-
uble drug can be evaluated for possible renal tox-
icity.
Perfusion offers special advantages in drug me-
tabolism studies: microsomes, cells, isolated tu-
bules, or tissue slices may give misleading results
because once the tissue is fragmented, a drug may
gain access to enzymes from which it will normally
be excluded in the intact kidney. Metabolism of a
drug by the isolated perfused kidney, however, can
be taken as a reasonably convincing demonstration
that the drug is metabolized by the kidney in vivo.
The appearance of metabolites of the drug in the
urine, or in the perfusion medium, or both, gives
further useful information about the site and extent
of drug metabolism in the intact kidney.
Special applications of the isolated perfused kidney
Determination of the rate of metabolism of the
drug. Serial samples taken from the recirculation
perfusion medium allow the rate of removal of drug
from the "blood" to be determined. Collection of
all of the urine formed during the experiment, anal-
ysis of the drug and its metabolites, together with
the determination of the amount of drug remaining
within the kidney at the end of perfusion, allows a
complete balance to be drawn up, and the maximum
rate of metabolism of the drug can be determined.
Comparison of luminal and contraluminal uptake
of a drug. The perfused kidney offers an indirect
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method of determining the site of uptake of a drug.
The filtered load of the drug may be calculated read-
ily from the GFR, measured as inulin clearance, and
the concentration of drug in the perfusate. Total
drug reabsorption from the filtrate then represents
the entry of drug into the tubular cell from the lumi-
nal surface. A comparison between the rate of filtra-
tionlreabsorption of the drug and the rate of its re-
moval from the perfusion medium can yield various
types of information. Thus, if the two rates concur,
as in the case of muramidase (lysozyme), the
"drug" must enter the cell from the luminal surface
only, and then be metabolized or retained within the
cell [3]. If, on the other hand, the rate of filtration!
reabsorption greatly exceeds the rate of removal of
the compound from the perfusate (as is the case
with sodium, or with light-chain immunoglobulins
[4], for example), the compound may be presumed
to enter largely from the luminal pole of the cell, but
then to return to the vascular system.
The third possibility, a rate of "metabolism" in
excess of the calculated filtered load, clearly in-
dicates that some of the drug enters by the con-
traluminal route. Examples include insulin, C pep-
tide [5], and many metabolic substrates [6].
Further evidence of the routes of entry. Modifica-
tions of the system of perfusion establish the routes
of renal handling and metabolism of drugs. Per-
fusion in the absence of albumin (to exclude pro-
tein-binding), the nonfiltering kidney model (to ex-
clude luminal presentation of the drug), and total
inhibition of drug reabsorption with iodoacetate (to
determine directly the filtered load of the drug) have
been used.
Albumin-free perfusion results in poor renal func-
tion. Sodium reabsorption is little over 50% of the
filtered load [7]. But GFR remains near-normal, and
the renal handling of compounds that are not pro-
tein-bound remains unchanged [4], with the advan-
tage that the filtered load of a foreign compound
added to the perfusate is truly the GFR times the
plasma concentration of the coumpound.
On the other hand, increasing the colloid osmotic
pressure of the artificial perfusion medium and re-
ducing the perfusion pressure results in normal per-
fusate flow but no urine production: a nonfiltering
kidney. This is a unique model in which to distin-
guish luminal and contraluminal entry of drugs into
the renal tubular cell, and, more usefully, to distin-
guish between different patterns of drug metabolism
that may result from exposure to different enzymes
within the kidney. Studies with insulin suggest that
there are two mechanisms of uptake and degrada-
tion of the hormone [5]. Other peptide hormones al-
so have been studied [8, 9].
Another method used to define the filtered load of
a foreign compound in the perfused kidney takes
advantage of the energy-dependence of pinocytosis.
lodoacetate totally inhibits the tubular reabsorption
of lysozyme [8] and of light-chain immunoglobulins
[4]. In the presence of the inhibitor, the urinary ex-
cretion equals the filtered load.
Influence of drugs on renal intermediary metabo-
lism. Drug effects on intermediary metabolism, on
adenine nucleotide levels, on intermediary metabo-
lite content of the freeze-clamped kidney [10, 11],
and on the maximum rate of gluconeogenesis, am-
moniagenesis, or oxygen consumption have been
demonstrated in the perfused kidney [12, 13].
Histologic localization of foreign compounds.
The rapid fixation of perfused organs by means of
glutaraldehyde injection permits accurate histologic
investigation. The method of "sandwich" immuno-
peroxidase staining [14] has been successfully ap-
plied to the problem of localizing lysozyme [3] and
light-chain immunoglobulins [4] in the perfused kid-
ney, and has much wider possibilities.
Disadvantages of the isolated perfused kidney in studies of
drug metabolism
Many of the processes that characterize drug me-
tabolism by the liver also occur in the kidney (re-
viewed by Anders and Hook in this issue). The
availability of the relevant cofactors in the perfused
kidney and the survival of the relevant conjugation
reactions have not been systematically studied,
however. Because the glutathione content of isolat-
ed perfused kidney is consistently lower than that
observed in vivo [2], the pattern of drug metabolites
may be distorted, or the maximum rates of drug me-
tabolism may not be achieved. There appears also
to be variability in the pathway of acetylation in the
perfused kidney [15].
As emphasized above, renal drug metabolism and
the effects of the drug on renal metabolism and
physiologic function require that the drug reaches a
particular cell or a particular site in the cell. Some
of the shortcomings in renal function observed in
the isolated, perfused rat kidney bear on this point:
(1) Low filtration fraction. The filtration fraction
determines the relative amounts of a drug delivered
to the luminal and contraluminal poles of tubular
cells. This localization dictates that a drug must be
filtered or secreted before it can be metabolized by
enzymes of the brush border membrane. It may also
determine the compartment, urine or plasma, in
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which metabolites are to be expected. These con-
siderations apply to the metabolism of paracetamol,
for the well-characterized enzymes of glutathione
metabolism are localized in the brush border mem-
brane.
(2) Distal tubule overload. DiMello and Maack
[17] have localized a defect in tubular reabsorption
by the isolated perfused kidney to the loop of
Henle. This results in the excessive delivery of fil-
trate to the distal tubule and may distort renal func-
tion in this preparation [34]. It is reassuring in this
respect that paracetamol reabsorption in the isolat-
ed kidney is identical to that found in vivo in the dog
[18].
(3) Failure of concentrating ability/loss of corti-
comedu/lary concentration gradients. These two
defects in the perfused kidney are thought to be
linked. Their importance in drug metabolism stud-
ies resides in the frequency with which intrarenal
drug distribution studies have shown marked local-
ization of a drug within the kidney. It is difficult to
know whether this distribution seen in vivo is
merely coincidental to the effects of the drug on re-
nal function or might influence the rate and pattern
of metabolism.
(4) Excessive flow rate and distorted distribution
of blood flow. In the perfused rat kidney, the flow
rate of the perfusion medium is up to ten times high-
er than the blood flow in vivo [2], and is distributed
approximately 2:1 between cortex and medulla. The
medulla may thereby be exposed to larger amounts
of a drug added to the circulation than is the me-
dulla in vivo. Perhaps this effect compensates in
part for the loss of drug concentrating ability in this
region discussed above, but it must remain a factor
in interpreting the results of drug metabolism stud-
ies.
Examples of drug effects in isolated perfused
kidney (Table 1)
It has been demonstrated that diuretic drugs re-
tain their in vivo activity when added to the medium
perfusing an isolated rat kidney. Freeze-clamping of
the kidney gives additional information on the mode
of action of the drug [10].
In general, the expected responses to hormones
have been obtained, and a number of other agents
with known pharmacologic effects have proved ef-
fective in the in vitro kidney; in fact, we have come
across no example to date of the failure to observe
the anticipated drug effect in the isolated perfused
kidney.
A number of other drugs, not particularly known
for their renal pharmacologic effect, have been
found to have discrete effects in vitro. In several
cases, excess potassium excretion, sometimes
achieving net potassium secretion, has been ob-
served with relatively low doses of drugs, such as
lysozyme [33], gentamicin [19], and tobramicin [45],
and this effect may play some part in the toxicity of
each of these agents [12].
Paracetamol (acetaminophen) and the kidney
Paracetamol (4-hydroxyacetanilide) is an analge-
sic drug with wide application. It is given either
alone or in conjunction with other analgesics, some
of which have been implicated in the syndrome of
analgesic nephropathy [20]. An important question
in association with the clinical problem of analgesic
nephropathy is whether paracetamol has any dam-
aging effects on the kidney. The close chemical rela-
tionship between paracetamol and phenacetin—
paracetamol is the major immediate metabolite of
phenacetin—-invites comparison with this drug.
Phenacetin probably does have a role in both anal-
gesic nephropathy and, rarely, in the production of
renal pelvic carcinoma. Nevertheless, convincing
evidence that paracetamol can itself produce kidney
damage is lacking.
Paracetamol is an extremely safe analgesic when
taken in therapeutic doses. In overdose, however,
the drug is toxic and can lead to hepatic necrosis,
which, in severe cases, may result in death. Histo-
logically, massive hepatic necrosis is seen in those
patients who die. In less severely affected cases,
more distinctive changes occur, with selective dam-
age to centrilobular areas.
Analysis of the urine of humans and animals after
therapeutic doses of paracetamol shows five major
components: paracetamol itself and four conju-
gates—paracetamol sulphate, paracetamol glucuro-
nide, paracetamol cysteine conjugate, and paraceta-
mol mercapturic acid. The main biotransformation
of paracetamol is direct conjugation with active sul-
phate or glucuronic acid to form the sulphate or glu-
curonide conjugates, respectively [21]. After thera-
peutic doses, most of the drug is excreted as a mix-
ture of the sulphate and glucuronide, with only a
small proportion being converted to the cysteine
conjugate or mercapturic acid.
With toxic doses of paracetamol, the pattern of
excretion changes dramatically. As the dose in-
creases, the proportion excreted as the sulphate or
glucuronide becomes limited [21, 22] whereas that
Table 1. Drug effects demonstrated in isolated perfused rat kidney
Drug Dose Effect Comments Ref.
Hormones
ADH
All as continuous infusion
Renin substrate (synthetic
tetradecepeptide)
SQ 20881
Saralasin
Phenylephrine
Isoprotorenol
Phenoxybenzamine
Propranolol
Diuretics
Acetazolamide
Other agents
Verapamil (iproveratril)
Iodoacetamide
Indomethacin
20 to 50 iiU!ml
20 to 50 mU/mi
0.1 to bOng/mi
10 to 7 M
50 to 100 x l0 M
5 ng/ml
5 ng!ml
4 mU/mi
1.5 to 6.0 ng/min
into 70 ml
100 nglminl7o ml
3 >< 10ri
1 x 106M
2 to 3 nglml
6ng/ml
10 M
5 x 104t
l0 M10M
4.4 x 106
10—2 M
5 x l06i
Increased urine osmolality
Vasoconstriction
Increased urine osmolality
Increased K excretion
Increased urine osmolality
Decreased urine Na+
Increased P04-excretion
Decreased Ca excretion
Increased cAMP excretion
Decreased urine Na+
Increased P04-excretion
Decreased Ca excretion
Increased cAMP excretion
Increased filtration fraction
Increased filtration fraction
Reverse effect of renin
substrate
Prevents All effect
Inhibits Na excretion
Inhibits Na excretion
Inhibits Na excretion
No inhibition of Na transport
Bicarbonaturia
Natriuresis lowers GFR
Natriuresis
Natriuresis
Inhibits autoregulation
Total inhibitor of Na
reabsorption
Inhibits prostaglandins
synthesis
Inhibits prostaglandins
synthesis
K excretion
Potassium excretion.
Inhibition of Na
reabsorption
Inhibition of Na
reabsorption. No effect on
K+ excretion
No pressor effect
Maximum U/Posm 1.12
No pressor effect
No effect on Na reabsorption
In the presence of
theophylline
Inhibited by /3 blocker
vasoconstnctor at higher
doses
No change in regional
perfusion
Dependent on HCO3
Increased GFR
Increased GFR
Converting enzyme inhibitor
All analogue
Additive with phenylephrine
Blocks vascular effect of
norepinephrine but not the
effect on Na excretion
Completely blocks effect of
norepinephrine
Phosphaturia, no increase in
cAMP excretion
Also inhibits glucose transport
K secretion
50% of Na reabsorption
survives. Bicarbonate!
chloride excretion. No
glycosuria.
Ca antagonist"
Inhibits pinocytosis
Also inhibits Na
reabsorption. Stimulates K
excretion
Inhibits Na reabsorption
[33]
[34]
[34]
[35]
[34]
[36]
[37]
[36]
[38]
[38]
Frega & Leaf,
unpub-
lished
[39]
[39]
[39]
[39]
[36]
[36]
[36]
[36]
[40]
Frega & Leaf,
unpub-
lished
[10]
[11]
[41]
[42]
[43]
[44]
[44]
[10]
[8]
[34]
excreted as the cysteine conjugate or mercapturic
acid increases.
Paracetamol is relatively stable, and it is a chem-
ically reactive metabolite of the drug, rather than
the drug itself, which is found to cause necrosis
[23].
It is known that the kidney has the ability to me-
tabolize certain drugs along a pathway involving a
reactive intermediate [24, 25], but in in vivo experi-
ments, it is impossible to differentiate between me-
tabolism occurring in the liver and metabolism oc-
curring in the kidney. It is, therefore, of great inter-
Desmopressin (DAVP)
Aldosterone
Dibutyryl cAMP
Norepinephrine
Epinephrine
PTH
b0 M
l0 M
Ethacrynic acid
Frusemide
Ouabain
Acetyl salicylate
Gentamicin
Tobramycin
Netilmicin
8 x l03M
20 /Lg/mI
1000 g/ml
100 JLg/mi
[34]
[19]
[45]
[45]
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est to answer the following questions: (1) Does
paracetamol enter renal tubular cells? (2) Is para-
cetamol, once within the kidney cell, metabolized at
a significant rate? (3) Does paracetamol, in hepato-
toxic doses, have any independent and direct ef-
fects on renal function? (4) Are any of the poten-
tially toxic metabolites that are found in the urine
after administration of the drug in vivo, formed
within the kidney? If so, what are the relative con-
tributions of liver and kidney to the observed rate of
paracetamol metabolism in vivo?
We have undertaken a study in the isolated per-
fused rat kidney which aims to extend our knowl-
edge of the renal handling and metabolism of para-
cetamol.
Renal handling of paracetamol. Over the range
of concentrations (1 to 3 mM), paracetamol was
both filtered at the glomerulus and largely reabsorbed
from the filtrate. Assuming free-filtration of para-
cetamol, and neglecting the small quantities of
paracetamol metabolites that also appeared in the
urine (see below), we found the fractional reab-
sorption to be approximately 74% of the filtered
load, at all concentrations of paracetamol tested.
This figure is very similar to that observed for
paracetamol reabsorption by the dog kidney in vivo
[18]. In this range of concentration, there was no
evidence of net secretion of paracetamol.
As the filtered load of paracetamol was increased,
an apparent maximal reabsorptive rate (Tm) be-
came apparent (Fig. 1), but this cannot be attributed
to a limitation of active transport in the usual sense.
Because high doses induce a diuresis, and because
paracetamol is reabsorbed by diffusion, the appar-
ent limitation of reabsorption results from the effect
of the induced diuresis on back diffusion.
Effect of paracetamol on renal tubular function.
Paracetamol in low doses has no acute effect on
renal tubular function, GFR, or sodium reabsorp-
tion. In contrast, at higher concentrations of para-
cetamol, there is an acute inhibition of renal tubular
function. First discernable at 10 m and above, an
immediate and marked diuresis occurred, and this
was accompanied by a decrease in the inulin clear-
ance and a reduction in sodium reabsorption (Fig.
2). A maximum inhibition of 50% sodium reabsorp-
tion and a three-fold increase in urine flow were re-
corded.
Direct evidence of renal metabolism of para-
cetamol. Reabsorption of paracetamol from the
filtrate indicates that paracetamol readily enters
renal cells. Evidence that paracetamol is metabo-
lized by the intact kidney was obtained by exam-
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Fig. 1. Paracetamol handling by the perfused kidney. Each point
is mean of six experiments. The apparent maximal reabsorptive
rate is approximately 12 smoIes/min.
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Fig. 2. Effect of increasing concentrations of paracetamol on so-
dium reabsorption and urine flow. Each point is mean of four to
six experiments.
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Table 2. Metabolism of paracetamol by the perfused rat kidneys
Concentration of
paracetamol
mM
Paracetamol Glucuronide Sulphate
Mercapturic acid
and cysteine
nmoles/hr/g kidney WI
2.4 0.2 (4) 7,090 2,500 124.0 56.9 32.7 15.6 32.6 12.7
3.4 0.4 (6) 10,000 4,290 76.9 55.6 60.0 28.5 37.7 14.8
a Values refer to total paracetamol or conjugates excreted during 60 mm of perfusion. The number of perfusions studied at each
concentration is shown in parentheses.
ining the urine produced after addition of para-
cetamol to the perfusate. The peaks obtained from
high-pressure liquid chromatography by ultraviolet
monitoring and tritium radioactivity, were closely
similar. They indicate the presence in the urine of
free paracetamol, paracetamol gluc uronide, sul-
phate, cysteine, and mercapturic acid conjugates
(Table 2). In the urine produced 30 mm after addi-
tion of 2.4 mmoles/liter paracetamol to the per-
fusate, paracetamol accounted for 92%, glucuro-
nide 1.1%, sulphate 0.9%, cysteine conjugate 0.5%,
and mercapturic acid 0.5% of the tritiated para-
cetamol recovered. The glutathione conjugate was
not detected, and none of the paracetamol con-
jugates were found in the perfusion medium. Cys-
teine conjugate was found to be an artefact of
mercapturic acid degradation during storage of
urine specimens. These two conjugates were, there-
fore, recorded collectively as mercapturic acid.
The rate of formation of the mercapturic acid
conjugate reached a maximum value of 65 nmoles/
hr/g of kidney at a concentration of approximately
10 ifiM paracetamol in the perfusate. Above this
concentration, mercapturic acid formation dropped
rapidly, and at the same time, there appeared in the
urine a new sulphur containing conjugate (Fig. 3).
In contrast, covalent binding of paracetamol to kid-
ney protein increased linearly with doses up to 25
mM paracetamol. Above this concentration, levels
of covalent binding remained constant. The sum of
mercapturic acid and the unknown sulphur contain-
ing conjugate, together with the amount of covalent
binding of paracetamol to protein, give a measure of
the capacity of the kidney to oxidatively metabolize
paracetamol (Fig. 4). Saturation of this pathway oc-
curs at levels of 10 mrvt paracetamol in the per-
fusate, and under these conditions, 80 to 100 nmoles
paracetamol are oxidatively metabolized per hour
per gram of kidney.
Discussion
The present studies have demonstrated the viabil-
ity of the perfused kidney as a model for the study
100
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Paracetamol, mM
Fig. 3. Effect of paracetamol concentration in perfusion on un-
nary excretion of metabolites. Points are individual experimental
values. Open symbols and solid line denotes mercapturic acid.
Closed symbols and broken line denotes unknown sulphur-con-
taining conjugate.
40
0 10 20 30 40
Paracetamol, mM
Fig. 4. Effect of paracetamol concentration in perfusion on cal-
culated amount of total sulphur-containing conjugates formed
(excreted in urine plus bound to kidney protein). For calculation
see text. Points are individual experiments.
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of renal drug metabolism. Under the acute condi-
tions simulated by this model, paracetamol appears
to be relatively nontoxic to the kidney. Extremely
high concentrations of paracetamol in the perfusate
were tequired before alteration to the functional
stability of the kidney was observed. This cone-
sponds well with the human situation where para-
cetamol overdose is usually related to hepatic ne-
crosis [26], and only a few cases of acute tubular
damage have been reported [27, 28].
Metabolism of paracetamol in a number of animal
species has been thoroughly investigated. Analysis
of urine after paracetamol administration shows
that only a small percentage of the dose is excreted
as paracetamol. The majority of paracetamol is ex-
creted as the glucuronide and sulphate conjugates,
whereas the amount of mercapturic acid and cys-
teine conjugate formed depends on the dose admin-
istered. There is no glutathione conjugate excreted.
(Calder and Hart, unpublished). The enzymes re-
sponsible for glucuronidation [29] and suiphation
[30] of drugs are present in the kidney. Drug oxida-
tion is usually catalyzed by cyt. P-450, and recent
work has localized the renal activity of cyt. P-450 to
the cortex, although induction of some activity in
the outer medulla is possible [311. In view of the fact
that 75 to 80% of the filtered load of paracetamol is
reabsorbed, it is apparent that a significant amount
of paracetamol passes through the tubular cells, and
is thus available for renal metabolism by these path-
ways.
Analysis of urine samples from perfusion experi-
ments detected the presence of all the conjugates
seen in vivo, thus confirming the presence of these
enzymic pathways in the kidney. The absence of
the glutathione and the cysteine conjugates in urine
following the perfusions tends to indicate that the
enzymic pathway subsequent to glutathione con-jugation is sufficient to successfully handle total
conversion of the glutathione conjugate to the mer-
capturic acid, This is in contrast to results obtained
by Jones et a! [45]. Using isolated renal tubules to
study paracetamol metabolism, these workers de-
tected the presence of the glutathione and cysteine
conjugates in addition to the mercapturic acid con-
jugate. This could reflect a decrease in the efficien-
cy of the enzymic pathway in a preparation when
the organ does not remain intact.
Of particular interest was the presence of the
mercapturic acid conjugate, because its formation
requires prior oxidation of paracetamol to a chem-
ically reactive intermediate, N-hydroxy para-
cetamol. The acute hepato-toxicity of paracetamol
is considered to be due to this toxic metabolite be-
cause under normal conditions it binds to gluta-
thione, but with high doses of paracetamol, gluta-
thione is depleted and the reactive intermediate
then binds to cell protein causing cell death [32].
Results from perfusion experiments suggest that a
similar but less damaging series of events occur in
the kidney. With low doses of paracetamol in the
perfusate, the majority of paracetamol that is oxi-
datively metabolized to N-hydroxy paracetamol re-
acts with glutathione and subsequently forms mer-
capturic acid. Higher doses of paracetamol result
initially in an increased binding of paracetamol to
kidney protein, possibly due to a decrease in gluta-
thione levels. This is followed by the appearance of
an unknown conjugate. Preliminary character-
ization of this compound indicates a sulphur con-
tent, so that it is likely to be derived from the gluta-
thione conjugate. It is not normally seen in rat
urine, and this suggests that at high concentrations
of paracetamol, an altered enzymic pathway for
breakdown of the glutathione conjugate in kidney is
involved. The fact that it appears only at excessive-
ly high concentrations of paracetamol explains why
acute kidney damage is so rarely observed in vivo.
Nevertheless, the demonstration of this pathway of
paracetamol metabolism in intact kidney leaves
open the question of whether more prolonged ex-
posure to paracetamol at lower concentrations in
vivo might produce renal damage and lead to the
syndrome of analgesic nephropathy.
Summary. The isolated perfused rat kidney can
be applied to the study of many aspects of drug ac-
tion and drug metabolism. Physiologic and bio-
chemical function of the isolated perfused kidney
has been used to confirm and extend knowledge
about the nature of action of drugs with effects on
the kidney. This method has advantages in studying
metabolic effects of drugs, whereas the limitations
of the technique stem from the reduced filtration
fraction and loss of corticomedullary concentration
gradients in the perfused kidney. Application of the
method to a study of paracetamol metabolism has
provided new insights into the mechanism of pos-
sible nephrotoxicity of this drug.
Paracetamol, which is freely filtered and reab-
sorbed, rapidly inhibited tubular sodium transport,
but only at doses over 10 mrvi. At doses seen in hu-
man patients, no measurable inhibition of renal
function occurred in the short-term perfusion ex-
periments. Two distinct pathways of paracetamol
metabolism in the isolated kidney are recognized—
one at low doses (below 10 mM) and the other pre-
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dominantly at high doses. The kidney has the ca-
pacity to produce toxic" metabolites of the drug.
Reprint requests to Dr. B. D. Ross, Nuffield Department of
Clinical Biochemistry, Oxford University, Oxford, England
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